Myoung-Ok Kwon

Myoung-Ok Kwon, Prof. PhD, currently serves as Co-Chair and member of the Evaluation Board at Wyss Zurich and holds the position of Adjunct Professor at the Korea Advanced Institute of Science and Technology. Kwon is also a Board Observer at Nanolive SA and a member of the Board of Directors at Neo Medical and Medimaps Group. Kwon has been a Partner at Swisscom Ventures since June 2021 and an Advisor and Head of Healthcare Investment at PMG Fonds Management AG since October 2018. Additionally, Kwon has been the Managing Partner at Julier Partners since January 2013. Previously, Kwon was an Independent Board Director at NLS Pharmaceutics AG from January 2021 to May 2023 and a Venture Partner at Arcus Ventures from August 2014 to August 2020. Kwon holds a PhD in Biochemistry from the University of Basel and has pursued Executive Education at Harvard Business School on multiple occasions.